Larson Financial Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16K Hold
11
– – ﹤0.01% 3389
2026
Q2
$825 Buy
+11
New +$707 ﹤0.01% 3379
2025
Q2
– Sell
-22
Closed -$1.4K – 3373
2025
Q1
$1.4K Buy
+22
New +$1.5K ﹤0.01% 2285

Other funds holding HAE

Larson Financial Group's HAE Position: Q3 2026 in Review

Larson Financial Group held its Haemonetics (HAE) position steady in Q3 2026 at 11 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.

Larson Financial Group first reported a position in HAE in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.4K in Q1 2025. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Larson Financial Group held 11 shares of Haemonetics worth $1.16K as of Q3 2026.
  • Larson Financial Group left its Haemonetics share count unchanged in Q3 2026.
  • Haemonetics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3389 holding.
  • Larson Financial Group first reported a position in Haemonetics in Q1 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Haemonetics position peaked at $1.4K in Q1 2025.
  • 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.